Fecal microbiota transfer for refractory intestinal graft-versus-host disease — experience from two German tertiary centers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: European journal of haematology, 107.2021, 2, S. 229-245
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
-
Goeser, Felix
Sifft, Barbara
Stein-Thöringer, Christoph
Farowski, Fedja
Straßburg, Christian P.
Brossart, Peter
Higgins, Paul G.
Scheid, Christoph
Wolf, Dominik
Holderried, Tobias Albert Wilhelm
Vehreschild, Maria J. G. T.
Cruz Aguilar, Marta Rebeca
- DOI
-
10.1111/ejh.13642
- URN
-
urn:nbn:de:hebis:30:3-723455
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goeser, Felix
- Sifft, Barbara
- Stein-Thöringer, Christoph
- Farowski, Fedja
- Straßburg, Christian P.
- Brossart, Peter
- Higgins, Paul G.
- Scheid, Christoph
- Wolf, Dominik
- Holderried, Tobias Albert Wilhelm
- Vehreschild, Maria J. G. T.
- Cruz Aguilar, Marta Rebeca
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
Murine Models of Steroid Refractory Graft-versus-Host Disease
Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease
Endothelial dysfunction during Graft-versus-Host Disease
Prognosefaktoren der chronischen Graft-versus-Host Krankheit
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
Murine Models of Steroid Refractory Graft-versus-Host Disease
Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease
Endothelial dysfunction during Graft-versus-Host Disease
Prognosefaktoren der chronischen Graft-versus-Host Krankheit
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
Murine Models of Steroid Refractory Graft-versus-Host Disease
Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease
Endothelial dysfunction during Graft-versus-Host Disease
Prognosefaktoren der chronischen Graft-versus-Host Krankheit